Huelsmann, P M; Hofmann, A D; Knoepfel, S A; Popp, J; Rauch, P; Di Giallonardo, F; Danke, C; Gueckel, E; Schambach, A; Wolff, H; Metzner, K J; Berens, C (2011). A suicide gene approach using the human pro-apoptotic protein tBid inhibits HIV-1 replication. BMC Biotechnology, 11:4.
Metzner, K J; Rauch, P; Braun, P; Knechten, H; Ehret, R; Korn, K; Kaiser, R; Sichtig, N; Ranneberg, B; van Lunzen, J; Walter, H (2011). Prevalence of key resistance mutations K65R, K103N, and M184V as minority HIV-1 variants in chronically HIV-1 infected, treatment-naïve patients. Journal of Clinical Virology, 50(2):156-161.
Metzner, K J; Rauch, P; von Wyl, V; Leemann, C; Grube, C; Kuster, H; Böni, J; Weber, R; Günthard, H F (2010). Efficient suppression of minority drug-resistant HIV type 1 (HIV-1) variants present at primary HIV-1 infection by ritonavir-boosted protease inhibitor-containing antiretroviral therapy. Journal of Infectious Diseases, 201(7):1063-1071.
Drogan, D; Rauch, P; Hoffmann, D; Walter, H; Metzner, K J (2010). The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro. Antiviral Research, 86(3):312-315.
Metzner, K J; Giulieri, S G; Knoepfel, S A; Rauch, P; Burgisser, P; Yerly, S; Günthard, H F; Cavassini, M (2009). Minority quasispecies of drug-resistant HIV-1 that lead to early therapy failure in treatment-naive and -adherent patients. Clinical Infectious Diseases, 48(2):239-247.
Knoepfel, S A; Salisch, N C; Huelsmann, P M; Rauch, P; Walter, H; Metzner, K J (2008). Comparison of G-to-A mutation frequencies induced by APOBEC3 proteins in H9 cells and peripheral blood mononuclear cells in the context of impaired processivities of drug-resistant human immunodeficiency virus type 1 reverse transcriptase variants. Journal of Virology, 82(13):6536-6545.
Azais, V; Arand, M; Rauch, P; Schramm, H; Bellenand, P; Narbonne, J F; Oesch, F; Pascal, G; Robertson, L W (1987). A time-course investigation of vitamin A levels and drug metabolizing enzyme activities in rats following a single treatment with prototypic polychlorinated biphenyls and DDT. Toxicology, 44(3):341-354.
Glatt, H R; Robertson, L W; Arand, M; Rauch, P; Schramm, H; Setiabudi, F; Pöchlauer, P; Müller, E P; Oesch, F (1986). cis- and trans-1,2-diphenylaziridines: induction of xenobiotic-metabolizing enzymes in rat liver and mutagenicity in Salmonella typhimurium. Archives of toxicology, 59(4):242-248.